The biological significance of tobacco-specific N-nitrosamines: Smoking and adenocarcinoma of the lung

Critical Reviews in Toxicology

Volumn 26, Issue 2, 1996, Pages 199-211

  Hoffmann, Dietrich ^a   Rivenson, Abraham ^a   Hecht, Stephen S ^a  

^a AMERICAN HEALTH FOUNDATION   (United States)

Author keywords

(NNK); 4 (methylnitrosamino) 1 (3 pyridyl) 1 butanone; K ras oncogene activation; Lung adenocarcinoma (AC); Metabolic activation; SCC; Squamous cell carcinoma; Tobacco specific N nitrosamines (TSNA)

Indexed keywords

4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANONE; NITROSAMINE;

CARCINOGENICITY; CIGARETTE SMOKING; HAMSTER; HUMAN; LUNG ADENOCARCINOMA; METABOLIC ACTIVATION; MOUSE; NONHUMAN; ONCOGENE; RAT; REVIEW; SMOKING; SQUAMOUS CELL CARCINOMA;

CRICETINAE; NICOTIANA TABACUM;

EID: 0029880858     PISSN: 10408444     EISSN: None     Source Type: Journal    
DOI: 10.3109/10408449609017931     Document Type: Review

References (76)

1. Hoffmann, D. and Spiegelhalder, B., Eds., Tobacco-specific nitrosamines. Round table discussion, 15th International Cancer Congress, August 1990, Hamburg, Germany, Crit. Rev. Toxicol., 21, 235, 1991.
2. International Agency for Research on Cancer, Tobacco Habits Other than Smoking; Betel Quid and Areca-Nut Chewing; and some Related Nitrosamines, IARC Monograph on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, Lyon, 37, 1985.
3. United States Surgeon General, The Health Consequences of Using Smokeless Tobacco, NIH Publ. No. 86-2874, 1986.
4. International Agency for Research on Cancer, Tobacco Smoking. IARC Monograph on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, Lyon, 1986, 38.
5. U.S. Surgeon General, Reducing the Health Consequences of Smoking. 25 Years of Progress, DHHS Publ. No. (CDC)89-8411, 1989.
6. Roberts, N. L., Natural tobacco flavor, Recent Adv. Tob. Sci., 14, 49, 1988.
7. Brunnemann, K. D. and Hoffmann, D., Chemical Composition of Tobacco Products, National Cancer Institute Smoking, Tobacco Control Monograph 2, Smokeless Tobacco and Health, NIH Publ. No. 93-3461, 1993.
8. Hoffmann, D. and Hoffmann, I., Tobacco consumption and lung cancer, in Lung Cancer. Advances in Basic and Clinical Research, H. H. Hansen, Ed., Kluwer, Boston, 1994, 1-42.
9. Wynder, E. L. and Graham, E. G., Tobacco smoking as a possible etiologic factor in bronchiogenic carcinoma, J. Am. Med. Assoc., 143, 329, 1950.
10. Wynder, E. L. and Stellman, S. D., Comparative epidemiology of tobacco-related cancers, Cancer Res., 37, 4608, 1977.
11. Wynder, E. L. and Covey, L. S., Epidemiologic patterns in lung cancer by histologic type, Eur. J. Cancer Clin. Oncol., 23, 1491, 1987.
12. El-Torky, M., El-Zeky, F., and Hall, J. C., Significant changes in the distribution of histologic type of lung cancer. A review of 4,928 cases, Cancer, 65, 1647, 1990.
13. Vincent, R. G., Pickren, J. W., Lane, W. W., Bross, I., Takita, H., Honten, L., Guierrez, A. C., and Rzepka, T., The changing histopathology of lung cancer, Cancer, 39, 1647, 1977.
14. Cox, J. D. and Yesner, R. A., Adenocarcinoma of the lung: recent results from the Veterans Administration lung group, Am. Rev. Respir. Dis., 120, 1025, 1979.
15. Johnston, W. W., Histologic and cytologic patterns of lung cancer in 2,580 men and women over a 15-year period, Acta. Cytol., 32, 163, 1988.
16. Cutler, S. J. and Young, J. L., Third National Cancer Survey: incidence data, J. Natl. Cancer Inst. Monogr., 41, 1, 1975.
17. Young, J. L., Percy, C. L., and Asire, A. J., Eds., Cancer incidence and mortality in the United States, 1973-1977, J. Natl. Cancer Inst. Monogr., 57, 1, 1981.
18. Beard, M. C., Annegers, J. F., Woolner, L. B., and Kurland, L. T., Bronchiogenic carcinoma in Olmsted County, 1935-1979, Cancer, 55, 2026, 1985.
19. Devesa, S. S., Shaw, G. L., and Blot, W. J., Changing patterns of lung cancer incidence by histologic type, Cancer Epidemiol. Biomarkers Prev., 1, 29, 1991.
20. Shopland, D. R., Eyre, H.-J., and Pechacek, T., Smoking-attributable cancer mortality in 1991: is lung cancer now the leading cause of death among smokers in the United States?, J. Natl. Cancer Inst., 83, 1142, 1991.
21. Hoffmann, D., Djordjevic, M. V., and Brunnemann, K. D., Changes in cigarette design and composition over time and how they influence the yields of smoke constituents, J. Smoking Relat. Disord., 6, 9, 1995.
22. Bradford, J. A., Harlan, W. R., and Hanmer, H. R., Nature of cigarette smoke. Technique of experimental smoking, Ind. Eng. Chem., 28, 836, 1936.
23. Pillsbury, H. C., Bright, C. C., O'Connor, K. J., and Irish, F. W., Tar and nicotine in cigarette smoke, J. Assoc. Off. Anal. Chem., 52, 458, 1969.
24. U.S. Surgeon General, The Health Consequences of Smoking. Nicotine Addiction, NIH Publ. No. 86-7874, 1986.
25. Russell, M. A. H., The case for mediumnicotine, low-tar, low-carbon monoxide cigarettes, Banbury Rep., 3, 297, 1980.
26. Herning, R. I., Jones, R. T., Bachman, J., and Mines, A. H., Puff volume increases when low-nicotine cigarettes are smoked, Br. Med. J. Clin. Res., 283, 187, 1981.
27. Kozlowski, L. T., Rickert, W. S., Pope, M. A., Robinson, J. C., and Frecker, R. C., Estimating the yield to smokers of tar, nicotine, and carbon monoxide from the "lowest yield" ventilated filter-cigarettes, Br. J. Addict., 77, 159, 1982.
28. Fagerström, K. O., Effects of a nicotine enriched cigarette on nicotine titration, daily cigarette consumption and levels of carbon monoxide, cotinine and nicotine, Psychopharmacology, 77, 164, 1982.
29. Haley, N. J., Sepkovic, D. W., Hoffmann, D., and Wynder, E. L., Cigarette smoking as a risk factor for cardiovascular disease. VI. Compensation with nicotine availability as a single variable, Clin. Pharmacol. Ther., 38, 164, 1985.
30. Puustinen, P., Olkkonen, H., Kolonen, S., and Tuomisto, J., Microcomputer-aided measurements of puff parameters during smoking of low- and medium-tar cigarettes, Scand. J. Clin. Lab. Invest., 47, 655, 1987.
31. Fischer, S., Spiegelhalder, B., and Preussmann, R., Influence of smoking parameters on the delivery of tobacco-specific nitrosamines in cigarette smoke: a contribution to relative risk evaluation, Carcinogenesis, 10, 1059, 1989.
32. Djordjevic, M. V., Sigountos, C. W., Brunnemann, K. D., and Hoffmann, D., Tobacco-specific nitrosamine delivery in the mainstream smoke of high- and low-yield cigarettes smoked with varying puff volumes, Abstr. CORESTA Symp., Kallithea, Greece, 1990, 54.
33. Lubin, J. H., Blot, W. J., Berrino, F., Flamant, R., Gillis, C. R., Kunze, M., Schmähl, D., and Visco, G., Patterns of lung cancer risk according to type of cigarette smoked, Int. J. Cancer, 33, 569, 1984.
34. Rivenson, A., Hecht, S. S., and Hoffmann, D., Carcinogenicity of tobacco-specific N-nitrosoamines (TSNA): the role of the vascular network in the selection of target organs. Crit. Rev. Toxicol., 21, 255, 1991.
35. Hoffmann, D., Brunnemann, K. D., Prokopczyk, B., and Djordjevic, M. V., Tobacco-specific N-nitrosamines and areca-derived N-nitrosamines: chemistry, biochemistry, carcinogenicity, and relevance to humans, J. Toxicol. Environ. Health, 41, 1, 1994.
36. LaVoie, E. J., Prokopczyk, B., Rigotty, J., Czech, A., Rivenson, A., and Adams, J. D., Tumorigenic activity of the tobacco-specific nitrosamines 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), 4-(methyl-nitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) and N′-nitrosonornicotine (NNN) on topical application to Sencar mice, Cancer Lett., 37, 277, 1987.
37. Hecht, S. S., Morse, M. A., Amin, S., Stoner, G. D., Jordan, K. G., Choi, C.-I., and Chung, F.-L., Rapid single-dose model for lung tumor induction in A/J mice by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and the effect of diet, Carcinogenesis, 10, 1901, 1989.
38. Hoffmann, D., Djordjevic, M. V., Rivenson, A., Zang, E., Desai, D., and Amin, S., A study of tobacco carcinogenesis. LI. Relative potencies of tobacco-specific N-nitrosamines as inducers of lung tumors in A/J mice, Cancer Lett., 71, 25, 1993.
39. Hecht, S. S., Isaacs, S., and Trushin, N., Lung tumor induction in A/J mice by the tobacco smoke carcinogens 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and benzo(a)pyrene: a potentially useful model for evaluation of chemopreventive agents, Carcinogenesis, 15, 2721, 1994.
40. Anderson, L. M., Hecht, S. S., Kovatch, R. M., Amin, S., Hoffmann, D., and Rice, J. M., Tumorigenicity of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in infant mice, Cancer Lett., 58, 177, 1991.
41. Prokopczyk, G., Rivenson, A., and Hoffmann, D. A study of betel quid carcinogenesis. IX. Comparative carcinogenicity of 3-methylnitrosaminopropionitrile (MNPN) and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) upon local applications to mouse skin and rat oral mucosa, Cancer Lett., 60, 151, 1991.
42. Lijinsky, W., Saavedra, J. E., and Kovatch, R. M., Carcinogenesis in rats by substituted dialkylnitrosamines given by gavage, In Vivo, 5, 85, 1991.
43. Rivenson, A., Hoffmann, D., Prokopczyk, B., Amin, S., and Hecht, S. S., A study of tobacco carcinogenesis. XLII. Induction of lung and pancreas tumors in F344 rats by tobacco-specific and areca-derived N-nitrosamines, Cancer Res., 48, 6912, 1988.
44. Hecht, S. S., Chen, C.-H. B., Ohmori, T., and Hoffmann, D., Comparative carcinogenicity in F344 rats of the tobacco-specific nitrosamines, N′-nitrosonornicotine and 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone, Cancer Res., 40, 298, 1980.
45. Hoffmann, D., Rivenson, A., Amin, S., and Hecht, S. S., Dose-response study on the carcinogenicity of tobacco-specific N-nitrosamines in F344 rats, J. Cancer Res. Clin. Oncol., 108, 81, 1984.
46. 6-methylguanine formation on Clara cells and induction of pulmonary neoplasia in the rat by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, Cancer Res., 50, 3772, 1990.
47. Lijinsky, W., Thomas, B. J., and Kovatch, R. M., Local and systemic carcinogenic effects of alkylating carcinogens in rats treated with intravesicular administration, Jpn. J. Cancer Res., 82, 980, 1991.
48. Hoffmann, D., Castonguay, A., Rivenson, A., and Hecht, S. S., Comparative carcinogenicity and metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and N′-nitrosonornicotine in Syrian golden hamsters, Cancer Res., 41, 2386, 1981.
49. Hecht, S. S., Adams, J. D., Numoto, S., and Hoffmann, D., Induction of respiratory tract tumors in Syrian golden hamsters by a single dose of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and the effect of smoke inhalation, Carcinogenesis, 4, 1287, 1983.
50. Schuller, H. M., Witschi, H.-P., Nylen, E., Joshi, P. A., Correa, E., and Becker, K. L., Pathobiology of lung tumors induced in hamsters by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and the modulating effect of hyperoxia, Cancer Res., 50, 1960, 1990.
51. Oreffo, V. I. C., Lin, H.-W., Padmanabhan, R., and Witschi, H., K-ras and p53 point mutations in 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced hamster lung tumors, Carcinogenesis, 14, 451, 1993.
52. Hecht, S. S., Jordan, K. G., Choi, C.-I., and Trushin, N., Effects of deuterium substitution on the tumorigenicity of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in A/J mice, Carcinogenesis, 11, 1017, 1990.
53. Boyland, E., Roe, J. C., and Gorrod, J. W., Induction of pulmonary tumors in mice by nitrosonornicotine, a possible constituent of tobacco smoke, Nature, 202, 1126, 1984.
54. Hoffmann, D., Raineri, R., Hecht, S. S., Maronpot, R., and Wynder, E. L., A study of tobacco Carcinogenesis. XIV. Effects of N′-nitrosonornicotine and N′-nitrosoanabasine in rats, J. Natl. Cancer Inst., 55, 977, 1975.
55. Hecht, S. S., Young, R., and Maeura, Y., Comparative carcinogenicity in F344 rats and Syrian golden hamsters of N′-nitrosonornicotine and N′-nitrosonornicotine-1-N-oxide, Cancer Lett., 20, 333, 1983.
56. Singer, G. M. and Taylor, H. W., Carcinogenicity of N′-nitrosonornicotine in Sprague-Dawley rats, J. Natl. Cancer Inst., 57, 1275, 1976.
57. Castonguay, A., Rivenson, A., Trushin, N., Reinhardt, J., Spathopoulos, S., Weiss, C., Reiss, B., and Hecht, S. S., Effects of chronic ethanol consumption on the metabolism and carcinogenicity of N′-nitrosonornicotine in F344 rats, Cancer Res., 44, 2285, 1984.
58. Griciute, L., Castegnaro, M., Bereziat, J. C., and Cabrai, J. R., Influences of ethyl alcohol on the carcinogenic activity of N-nitrosonornicotine, Cancer Lett., 31, 267, 1986.
59. Hilfrich, J., Hecht, S. S., and Hoffmann, D., A study of tobacco carcinogenesis. XV. Effects of N′-nitrosonornicotine and ′′-nitrosoanabasine in Syrian golden hamsters, Cancer Lett., 2, 169, 1977.
60. McCoy, G. D., Hecht, S. S., Katayama, S., and Wynder, E. L., Differential effect of chronic ethanol consumption on the carcinogenicity of ′-nitrosopyrrolidine and N′-nitrosonornicotine in male Syrian golden hamsters, Cancer Res., 41, 2849, 1981.
61. Koppang, N., Rivenson, A., Reith, A., Dahle, H. K., Evensen, O., and Hoffmann, D., A study of tobacco carcinogenesis. XLVIII. Carcinogenicity of N′-nitrosonornicotine in mink (Mustela vison), Carcinogenesis, 13, 1957, 1992.
62. Boyland, E., Roe, F. J. C., Gorrod, J. W., and Mitchley, B. C. V., The carcinogenicity of nitrosoanabasine, a possible constituent of tobacco smoke, Br. J. Cancer, 18, 265, 1964.
63. Brunnemann, K. D., Rivenson, A., Czech, A., LaVoie, E. J., and Hoffmann, D., Isolation, identification, and bioassay of the tobacco-specific N-nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol, Proc. Am. Assoc. Cancer Res., 29, 84, 1988.
64. Rivenson, A., Djordjevic, M. V., Amin, S., and Hoffmann, D., A study of tobacco carcinogenesis. XLIV. Bioassay in A/J mice of some N-nitrosamines, Cancer Lett., 47, 111, 1989.
65. Hecht, S. S. and Hoffmann, D., 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone, a nicotine-derived tobacco-specific nitrosamine, and cancer of the lung and pancreas in humans, in Origin of Human Cancer. A. Comprehensive Review, Brugge, J., Curran, T., Harlow, E., and McCormick, F., Eds., Cold Spring Harbor Laboratories, Cold Spring Harbor, NY, 1991, 745.
66. Hecht, S. S. and Hoffmann, D., The relevance of tobacco-specific nitrosamines in human cancer, Cancer Surv., 8, 273, 1989.
67. Hecht, S. S., Trushin, N., Castonguay, A., and Rivenson, A., A comparative tumorigenicity of DNA methylation in F344 rats by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and N-nitrosomethylamine, Cancer Res., 46, 498, 1986.
68. 6-Methylguanine is a critical determinant of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone tumorigenesis in A/J mouse lung, Cancer Res., 51, 5551, 1991.
69. Belinsky, S. A., Devereaux, T. R., Maronpot, R. R., Stoner, G. D., and Anderson, M. W., Relationship between the formation of promutagenic adducts and the activation of the K-ras protooncogene in lung tumors in A/J mice treated with nitrosamines, Cancer Res., 49, 5305, 1989.
70. 32P-postlabeling analysis of 7-methylguanine in human bronchial and lymphocyte DNA, Carcinogenesis, 14, 151, 1993.
71. Foiles, P. G., Akerkar, S. A., Carmella, S. G., Kagan, M., Stoner, G. D., Resau, J. H., and Hecht, S. S., Mass spectrometric analysis of tobacco-specific nitrosamine-DNA adducts in smokers and nonsmokers, Chem. Res. Toxicol., 4, 364, 1991.
72. Rodenhuis, S. and Slebos, R. J. C., Clinical significance of ras oncogene activation in human lung cancer, Cancer Res. Suppl., 52, 2665s, 1992.
73. Kobayashi, T., Tsuda, H., Nognchi, M., Hirohashi, S., Shimosato, Y., Goya, T., and Hayata, Y., Association of point mutation in c-Ki-ras oncogene in lung adenocarcinoma with particular reference to cytologic subtypes, Cancer, 66, 289, 1990.
74. Belinsky, S. A., Devereaux, T. R., White, C. M., Foley, J. F., Maronpot, R. R., and Anderson, M. W., Role of Clara cells and type II cells in the development of pulmonary tumors in rats and mice following exposure to a tobacco-specific nitrosamine, Exp. Lung Res., 17, 263, 1991.
75. Ronai, Z. A., Gradia, S., Peterson, L. A., and Hecht, S. S., G to A transitions and G to T transversions in codon 12 of the Ki-ras oncogene isolated from mouse lung tumors induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and related DNA methylating and pyridyloxobutylating agents, Carcinogenesis, 14, 2419, 1993.
76. Hoffmann, D., Rivenson, A., Murphy, S. E., Chung, F.-L., Amin, S., and Hecht, S. S., Cigarette smoking and adenocarcinoma of the lung: the relevance of nicotine-derived N-nitrosamines, J. Smoking-Relat. Disord., 4, 165, 1993.